Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø News

Home
Menu

First ‘gene silencing’ drug for Alzheimer’s disease shows promise

24 April 2023

A world-first trial at Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø and Ïã¸ÛÁùºÏ²ÊÖÐÌØÍøH led by Dr Catherine Mummery (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Queen Square Institute of Neurology)Ìýhas found a new genetic therapy for Alzheimer’s disease that is able to safely and successfully lower levels of the harmful tau protein known to cause the disease.

, (republished in ), , , Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø News